Loading...

TerrAscend Corp.

TER.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$2.38
CA$-0.01(-0.42%)

TerrAscend Corp. TER.CN Peers

See (TER.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$8.83+1.03%3.3B-55.19-CA$0.16N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
GTII.CNCA$7.19-0.96%1.7B24.79CA$0.29N/A
CRON.TOCA$2.60-0.38%1B13.68CA$0.19N/A
TRUL.CNCA$4.81-2.63%911.7M-4.50-CA$1.07N/A
CURA.TOCA$1.10-4.35%833.4M-2.47-CA$0.45N/A
DHT-UN.TOCA$13.40+0.15%748.6M335.00CA$0.04+3.76%
GUD.TOCA$5.75+0.00%572.9M57.50CA$0.10N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

TER.CN vs CURA.CN Comparison

TER.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TER.CN stands at 804.8M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, TER.CN is priced at CA$2.38, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TER.CN currently has a P/E ratio of -1.33, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, TER.CN's ROE is -0.33%, compared to CURA.CN's ROE of -0.25%. Regarding short-term risk, TER.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for TER.CN.

Stock Price Comparison

Loading...

Frequently Asked Questions

;